Mariner, LLC Adaptive Biotechnologies Corp Transaction History

Mariner, LLC

  • $55.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$3.46 - $5.33 $36,672 - $56,492
10,599 New
10,599 $51,000
Q1 2023

May 12, 2023
SELL
$7.8 - $10.11 $26,980 - $34,970
-3,459 Reduced 21.0%
13,012 $115,000
Q4 2022

Feb 14, 2023
BUY
$6.26 - $9.34 $103,108 - $153,839
16,471 New
16,471 $126,000

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email